Society ❯ Ethics

Reproductive Rights

Abortion Abortion Access Abortion Debate Women's Rights Pro-Life Movement Abortion Rights Women's Health Access to Healthcare Public Opinion Anti-Abortion Movement

Judge Pauses Louisiana Challenge, Leaves Mail-Order Abortion Pill Policy Intact

The court stay gives the FDA time to finish a promised safety review of mifepristone.

Montgomery County Man Charged After Alleged Covert Abortion Drug Leads to Stillbirth

Spanish Prosecutors Ask Equality Ministry to Block 13 Foreign Surrogacy Websites

Live Action Urges HHS and FDA to Suspend Mifepristone After Undercover Planned Parenthood Calls

Republicans Push to Restore In‑Person Rules for Abortion Pill at Fiery Senate Hearing

NRW Couple Who Turned to a U.S. Surrogate Press for Legalization in Germany

Kentucky Prosecutor Drops Fetal Homicide Charge in Self-Managed Abortion Case

Louisiana Joins Texas, Florida in New Court Moves Targeting FDA Abortion Pill Rules

Hawley Pressures FDA Chief as Anti‑Abortion Groups Demand Firing Over Reported Mifepristone Review Delay

Missouri, Kansas and Idaho Sue to Block FDA’s New Generic Mifepristone Approval, Curb Mail-Order Access

Spain's Health Ministry to Sue Madrid Over Refusal to Create Abortion Objectors Registry

Florida Sues Planned Parenthood Over ‘Safer Than Tylenol’ Abortion Pill Claim, Seeks $350 Million

Senate Democrats Press FDA on Mifepristone Review After Court Strikes Down Restrictions

Brazil's Supreme Court Overturns Barroso Order Allowing Nurses in Legal Abortions in 10–1 Vote

17 GOP Senators Press FDA Over Generic Mifepristone Approval

Madrid Puts Abortion Objector Registry on Hold as Ayuso Hints at Legal Fight

GOP Senators Move to Curb Mifepristone After FDA Clears Second Generic

51 GOP Senators Press FDA and HHS to Curb Abortion Pill Access After New Generic Approval

FDA Confirms Safety Review of Mifepristone With No Regulatory Changes Yet

FDA Approves Second Generic Mifepristone as White House Cites Legal Obligation